Willem de Vos, Prof. at University of Wageningen; Patrice Cani, Prof. at UCLouvain; Jean-Christophe Malrieu, CEO A-Mansia:
"As founders and CEO of A-mansia BioTech we experienced essential support from the VIVES Fund that allowed for a fruitful Series A funding to commercializing Akkermansia and capitalizing on science discoveries at UCLouvain and Wageningen University."